A comprehensive high cost drugs dataset from the NHS in England - An OpenSAFELY-TPP Short Data Report
Rowan A, Bates C, Hulme W, Evans D, Davy S, Kennedy N, Galloway J, Mansfield K, Bechman K, Matthewman J, Yates M, Brown J, Schultze A, Norton S, Walker A, Morton C, Bhaskaran K, Rentsch C, Williamson E, Croker R, Bacon S, Hickman G, Ward T, Green A, Fisher L, Curtis H, Tazare J, Eggo R, Inglesby P, Cockburn J, McDonald H, Mathur R, Wong A, Forbes H, Parry J, Hester F, Harper S, Douglas I, Smeeth L, Tomlinson L, Lees C, Evans S, Smith C, Langan S, Mehkar A, MacKenna B, Goldacre B. A comprehensive high cost drugs dataset from the NHS in England - An OpenSAFELY-TPP Short Data Report. Wellcome Open Research 2021, 6: 360. PMID: 35634533, PMCID: PMC9120928, DOI: 10.12688/wellcomeopenres.17360.1.Peer-Reviewed Original ResearchHigh-cost drugsSevere COVID-19 outcomesMonths of drugUnique patient IDCOVID-19 outcomesCOVID-19 pandemicLong-term conditionsNHS DigitalNHS EnglandCertain medicinesPatientsSpecialist medicinePatient IDDrugsDrug namesHospitalAverage numberMedicine dataMedicineDescriptive analysisReportYearsOpenSAFELYPandemicData reports
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply